Back to search

Article

Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalisation and death in the post vaccination era: A systematic review.

2024-01-30

Abstract excerpt

Immunocompromised individuals have been shown to mount a reduced response to vaccination, resulting in reduced vaccine effectiveness in this cohort. Therefore, in the post vaccination era, immunocompromised individuals remain at high risk of breakthrough infection and COVID-19 related hospitalisation and death. There has been a marked paucity of systematic review evaluating existing data describing the clinical me...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
625ee023-40fb-5dab-aee7-423086487660
DOI
10.22541/au.170663752.23533095/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunocompromised individuals are at increased risk of COVID-19 breakthrough infection, hospitalisation and death in the post vaccination era: A systematic review.DOI 10.22541/au.170663752.23533095/v1
Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2Semantic proximity
Uptake, effectiveness and safety of COVID-19 vaccines in the immunocompromised population: A population-based cohort study in EnglandSemantic proximity
Unveiling Protection: A Meta-Analysis of Tixagevimab-Cilgavimab Prophylaxis in 28,950 Transplant Recipients and Immunocompromised Patients Against COVID-19Semantic proximity
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELYSemantic proximity
Immunogenicity of COVID-19 mRNA Vaccines in Immunocompromised Patients: A Systematic Review and Meta-AnalysisSemantic proximity
Systematic review of the clinical effectiveness of Tixagevimab/Cilgavimab for prophylaxis of COVID-19 in immunocompromised patientsSemantic proximity
A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections – Risk Factors and Vaccine EffectivenessSemantic proximity
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population; A systematic review and meta-analysisSemantic proximity
Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individualsSemantic proximity
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trialSemantic proximity
Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbiditiesSemantic proximity
COVID-19 convalescent plasma for the treatment of immunocompromised patients: a systematic reviewSemantic proximity
Select a neighboring publication to make it the new centre.